Behind every great organization is a team of dedicated leaders. Our team brings a wealth of experience from across the industry.

CTN2 Officers & Advisors: Phil Cestaro Executive Director, Karen Johnson, Steve Schwab, Steve Goodman President and CEO, Robert Davis, William Mason, and Ari VanderWalde Medical Director

CTN2 Officers & Advisors

President & CEO, CTN2
Vice Chancellor for Research, UTHSC

Steven R. Goodman, PhD

Phil Cestaro

Executive Director & Treasurer, CTN2

Medical Director, CTN2

Chair, UTHSC Clinical Trials Governance Board; Associate Vice Chancellor for Research - Clinical Trials, UTHSC

Ari VanderWalde, MD, MPH, MBioeth

Secretary & General Counsel, CTN2
 Secretary & General Counsel, UTRF; Partner, Kennerly, Montgomery & Finely, P.C.

William Mason, JD

Robert Davis, MD, MPH

Governor's Chair, UTHSC-ORNL Center for Biomedical Informatics

Co-Director Tennessee Clinical and Translation Science Institute, Co-Chair of the Clinical Trial-Governance Board

Karen C. Johnson, MD, MPH

CTN2 Board of Directors

We are governed by a Board of Directors comprised of a representative from each participating institution, the UTHSC Chancellor, and from UTRF.

Martin A. Croce, MD, FACS

Senior Vice President and Chief Medical Officer, Regional One Health

 Professor of Surgery, UTHSC

John Jefferies, MD, MPH, FAAP, FACC, FAHA, FHFSA

Jay M. Sullivan Endowed Chair in Cardiovascular Medicine and Chief of Cardiology, UTHSC 

Co-director UT Methodist Institute for Cardiovascular Science

Steve J. Schwab, MD

Chancellor, UTHSC

Steven R. Goodman, PhD

Vice Chancellor for Research, UTHSC

Richard Magid, PhD

Vice President, UTRF UTHSC Office

Steven R. Ross, PhD, MS

Senior Vice President of Strategic Development, UT Medical Center & University Health System, Inc.

Giuseppe Pizzorno, PhD, PharmD

Chief Research Officer, Erlanger Health System, Professor and Associate Dean of Research, UTHSC

Geoffrey Smallwood, PhD

Chief Academic Officer,
Saint Thomas Health

Courtney Love, BA

Executive Director of Performance Management and Strategy, University Clinical Health

Lee Schwartzberg, MD, FACP

Executive Director of the West Cancer Center, Professor of Medicine UTHSC

Sue Theus, PhD

Associate Chief of Staff for Research, VA Medical Center Memphis



In order to sustain a successful, state-wide multi-site clinical trials network, each participating hospital appoints a Site Director. While executive level communication is maintained through Board representatives, CTN2 routinely works with each participating institution's Site Director as the lead on conduct of clinical trials. CTN2 develops working practice guidelines with each participating institution, customized to each institution's particular requirements, policies and environments. CTN2's site liaison and the Site Directors take the lead in developing and implementing those standards and operating procedures to facilitate prompt compliant and effective administration of clinical trials. The Site Director is also regularly consulted on potential and pending clinical trials in the pipeline. The Site Director is the main administrative contact for the TN-EDW data transfer facilitation, and inevitably a key person in the hospital on deploying TN-EDW as a tool for researchers. 

CTN2 Site Liaison Director

Sandra Dodd, RN, CCRC Memphis,TN

Erlanger Health System

Jennifer Burgess | Chattanooga, TN

Methodist Le Bonheur Healthcare

Memphis, TN

Regional One Health

Memphis, TN

Saint Thomas Health

Nashville, TN

University of Tennessee Medical Center

Janet Parkey, CPA, CGMA & Brandy Herbert, BSN, RN | Knoxville,TN

West Cancer Center

Eboney Ingram-Ware | Memphis,TN

Memphis Veterans Affairs


University Clinical Health


How about we talk some time?

Questions about our organization, structure, or participation benefits? We'd love to hear from you!

Phone: (901)866-1428

©2019 by Clinical Trials Network of Tennessee "CTN2".